HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Low dose of oral alendronate decreases bone turnover in Japanese patients with Paget's disease of bone.

AuthorsJunichi Takada, Kousuke Iba, Toshihiko Yamashita
JournalJournal of bone and mineral metabolism (J Bone Miner Metab) Vol. 23 Issue 4 Pg. 333-6 ( 2005) ISSN: 0914-8779 [Print] Japan
PMID15981032 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Amino Acids
  • Biomarkers
  • Collagen Type I
  • Peptides
  • collagen type I trimeric cross-linked peptide
  • deoxypyridinoline
  • Collagen
  • Alkaline Phosphatase
  • Alendronate
Topics
  • Administration, Oral
  • Aged
  • Alendronate (administration & dosage)
  • Alkaline Phosphatase (blood)
  • Amino Acids (urine)
  • Biomarkers (metabolism)
  • Bone Remodeling (drug effects)
  • Bone Resorption (drug therapy, physiopathology)
  • Collagen (urine)
  • Collagen Type I
  • Female
  • Humans
  • Japan
  • Male
  • Osteitis Deformans (drug therapy, physiopathology)
  • Osteogenesis (drug effects)
  • Peptides (urine)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: